ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Northern TK Venture Pte Ltd, Fortis Healthcare's promoter, has appealed a Tokyo District Court judgment to the Tokyo High Court. The litigation concerns losses related to delayed tender offer approvals.
Fortis Hospotel signed definitive agreements with SLJ Society to provide healthcare services at their 400+ bed hospital. Fortis will provide a ₹567 Crore loan.
Tokyo District Court dismissed all NTK claims against Daiichi Sankyo; NTK must bear litigation costs. NTK is reviewing the judgment and evaluating appeal options.
Management conference call discussing a Delhi High Court order regarding a forensic audit. Operating plans, including capex, bed expansion, and M&A, remain unaffected and fully funded by internal accruals.
Fortis Q1FY27 consolidated revenue grew 17.5% YoY to INR 2,545 Cr. Consolidated Operating EBITDA rose 15.8% to INR 568 Cr with a 22.3% margin.
Fortis Healthcare Ltd reported revenue from operations of ₹2,545 Cr (+17.5% YoY) and net profit of ₹272.8 Cr (+2.2% YoY) for Q1 FY27.
Fortis reported strong FY26 performance with 17.3% revenue growth and 31.5% PAT growth. Strategy focuses on brownfield expansion and diagnostic margin improvement.
Fortis Healthcare Ltd reported revenue from operations of ₹2,365 Cr (+17.8% YoY) and net profit of ₹271.2 Cr (+44.3% YoY) for Q4 FY26.